Percutaneous Microwave Ablation (MWA) of Malignant Tumors

What is percutaneous microwave ablation (MWA) of malignant tumors? 

Percutaneous microwave ablation (MWA) is a minimally invasive, precise, image-guided therapy of malignant tumors or solitary metastases of abdominal organs that is performed in oncology patients. It achieves an oncological effect comparable to surgical resection, without the need for extensive organ resection, but with significantly shorter recovery period and a lower complications rate.

The approximate duration of the procedure is about 60 minutes with anesthesia.

What are the indications for percutaneous microwave ablation (MWA) of malignant tumors? 

Candidates are oncology patients with malignant tumors or with solitary metastases of abdominal organs (liver, kidneys, soft tissues).

Percutaneous microwave ablation (MWA) is indicated for early stages of kindey cancer (up to 4 cm), liver cancer (HCC up to 5 cm) and oligometastatic liver disease (up to 4 cm)